Publication not explained
This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.
If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.
Featured Image
Read the Original
This page is a summary of: Real-world evaluation of Hba1c, blood pressure, and weight loss among patients with type 2 diabetes mellitus treated with canagliflozin: an analysis of electronic medical records from a network of hospitals in Florida, Current Medical Research and Opinion, March 2018, Taylor & Francis,
DOI: 10.1080/03007995.2018.1444591.
You can read the full text:
Contributors
The following have contributed to this page
